New cancer clinical trial: Identification of Molecular Biomarkers for Cancer Target Therapy Efficacy

Published on: October 30, 2018 at 12:00PM
Condition:   Cancer
Interventions:   Other: RNA sequencing;   Other: Transcriptome analysis;   Drug: target drug with the score above 0,1;   Drug: target drug with the score equal or below 0,1;   Drug: non-target drug;   Drug: palliative care
Sponsors:   OmicsWay Corp.;   Oncobox Ltd;   Vitamed LLC;   N.N. Blokhin National Medical Research Center of Oncology;   Kaluga Regional Clinical Oncology Center;   Multidisciplinary medical holding SM-Clinic;   Oncological Clinical Dispensary No. 1 of the Moscow City Health Department
Recruiting
https://ift.tt/2qin3K1